Publication:
Cardiac intervention before liver transplantation

dc.contributor.coauthorN/A
dc.contributor.departmentN/A
dc.contributor.kuauthorImam, Ashraf
dc.contributor.kuauthorKarataş, Cihan
dc.contributor.kuauthorMecit, Nesimi
dc.contributor.kuauthorKalayoğlu, Münci
dc.contributor.kuauthorKanmaz, Turan
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileDoctor
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteN/A
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.unitKoç University Hospital
dc.contributor.unitKoç University Hospital
dc.contributor.unitKoç University Hospital
dc.contributor.unitKoç University Hospital
dc.contributor.unitN/A
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokid275799
dc.date.accessioned2024-11-09T23:26:27Z
dc.date.issued2021
dc.description.abstractBackground. Cardiovascular complication is one of the leading causes of mortality after liver transplantation (LT). Thus, a thorough cardiac evaluation is a must before proceeding to a liver transplant surgery. Percutaneous coronary intervention (PCI) with stent and to a lesser extent coronary artery bypass grafting (CABG) are both valuable treatment options for patients with coronary artery disease. Methods. A retrospective, single-center study that included patients who underwent cardiac intervention and subsequent LT for end-stage liver disease. All patients who had PCI or CABG were included in the study. Results. Twenty-nine adult patients out of 51 had a cardiac intervention before liver transplantation. Twenty-four patients had a diagnostic PCI, 3 patients had therapeutic PCI with stent, and 2 had failed PCI and proceeded to CABG before liver transplant. The mean age of the patients was 60.5 years. There were 24 men. All patients had cirrhosis. The 2 CABG cases were done during the same admission with a 13- and 18-day interval between the CABG and the transplantation. Both cases were live-related liver transplantation. No mortality was reported. Conclusion. In case of PCI failure, CABG may be a valuable and safe treatment option for cirrhotic patients as a preparation for liver transplantation. Live donor liver transplantation may be a good back-up for those patients in case they develop hepatic decompensation.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue5
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.volume53
dc.identifier.doi10.1016/j.transproceed.2021.03.012
dc.identifier.eissn1873-2623
dc.identifier.issn0041-1345
dc.identifier.scopus2-s2.0-85104593828
dc.identifier.urihttp://dx.doi.org/10.1016/j.transproceed.2021.03.012
dc.identifier.urihttps://hdl.handle.net/20.500.14288/11555
dc.identifier.wos668604400036
dc.keywordsCoronary-artery-disease
dc.keywordsSurgery
dc.keywordsSafety
dc.languageEnglish
dc.publisherElsevier Science Inc
dc.sourceTransplantation Proceedings
dc.subjectImmunology
dc.subjectSurgery
dc.subjectTransplantation
dc.titleCardiac intervention before liver transplantation
dc.typeConference proceeding
dspace.entity.typePublication
local.contributor.authorid0000-0003-0172-3844
local.contributor.authorid0000-0003-1385-741X
local.contributor.authoridN/A
local.contributor.authoridN/A
local.contributor.authorid0000-0003-1886-7721
local.contributor.kuauthorImam, Ashraf
local.contributor.kuauthorKarataş, Cihan
local.contributor.kuauthorMecit, Nesimi
local.contributor.kuauthorKalayoğlu, Münci
local.contributor.kuauthorKanmaz, Turan

Files